BALB/cJGpt-Pdcd1em1Cin(hPDCD1)Cd274tm1(hCD274)Tnfrsf9em1Cin(hTNFRSF9)/Gpt
BALB/c-hPD1/hPDL1/hCD137|Strain NO.T007056
Knockin (KI)
- Product Type:
- Quantity: - +
- Sex:
- Age:
- Genotype:
BASIC INFORMATION
Strain Name: | BALB/cJGpt-Pdcd1em1Cin(hPDCD1)Cd274tm1(hCD274)Tnfrsf9em1Cin(hTNFRSF9)/Gpt |
Strain Number: | T007056 |
Official Symbol: | PDCD1,TNFRSF9,Cd274,CD274,Pdcd1,Tnfrsf9 |
Strain Strategy: | T007056.BALB_c-hPD1_hPDL1_hCD137.strain info.pdf |
Official Full Name: | programmed cell death 1,TNF receptor superfamily member 9,CD274 antigen,CD274 molecule |
Also Known As: | Ly101,PD-1,Pdc1,4-1BB,CD137,CDw137,ILA,A530045L16Rik,B7h1,Pdcd1l1,Pdcd1 |
NCBI Number: | 1856651332194236046053329126 |
MGI Number: | 1101059 |
Research Areas: | Humanized model,Gene humanization model,Humanization of tumor targets |
Strain Background: | [N000020] BALB/cJGpt |
Modification Type: | Knockin (KI) |
Inventory Status: | Cryopreserved |
Sale Status: | IF (Available for Distribution) |
Health Status: | Specific pathogen free (SPF) |
Publications: | 1. Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer |